PURE Bioscience (OTCMKTS:PURE) Share Price Crosses Above 200-Day Moving Average – Time to Sell?

PURE Bioscience (OTCMKTS:PURE – Get Free Report) crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $0.07 and traded as high as $0.0815. PURE Bioscience shares last traded at $0.0752, with a volume of 34,455 shares.

PURE Bioscience Stock Performance

The stock’s 50-day simple moving average is $0.07 and its 200 day simple moving average is $0.07. The company has a market capitalization of $8.85 million, a PE ratio of -2.27 and a beta of 0.33.

About PURE Bioscience

(Get Free Report)

PURE Bioscience, Inc develops and commercializes antimicrobial products based on its proprietary silver dihydrogen citrate (SDC) technology. SDC is designed to provide broad-spectrum antimicrobial activity while serving as the active ingredient in disinfecting, sanitizing, and hygiene formulations.

The company’s product portfolio has included PURE-branded solutions for hard-surface disinfection and sanitation, as well as applications in food safety, commercial and industrial settings, healthcare, and other environments where microbial control is important.

Featured Stories

• Five stocks we like better than PURE Bioscience
• ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
• Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
• AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
• Beyond the GPU: Credo Paves the Next AI Data Superhighway